Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: A Study to Evaluate the Safety and Pharmacokinetics of UI087 Compared to Coadministration of UIC202506, UIC202507 and UIC202508 in Healthy Adult Volunteers Under Fasting Conditions [Phase 1]
Phase 1 study to evaluate the safety and pharmacokinetics of UI087 compared with coadministration of UIC202506, UIC202507, and UIC202508 in …
-
EMA approval · 2026-04-22EMA Authorised: Forxiga (dapagliflozin propanediol monohydrate) — AstraZeneca AB
EMA authorised Forxiga (dapagliflozin propanediol monohydrate) for type 2 diabetes mellitus, heart failure (systolic), and chronic kidney di…
-
CLINICAL_TRIALS trial_result · 2026-04-22Clinical Trial Update: A Study of Orforglipron (LY3502970) in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Diet and Exercise Alone [Phase 3]
Orforglipron (LY3502970) in adults with type 2 diabetes mellitus and inadequate glycemic control has completed a Phase 3 trial, and results …
-
EMA approval · 2026-04-22EMA Authorised: Rybelsus (semaglutide) — Novo Nordisk A/S
The European Medicines Agency authorised Rybelsus (semaglutide) by Novo Nordisk A/S for the treatment of Type 2 diabetes mellitus.
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: Efficacy and Safety of Triple Therapy With Dulaglutide, SGLT2 Inhibitors, and Finerenone in Chinese Adults With Type 2 Diabetes and Chronic Kidney Disease [Phase 4]
Phase 4 clinical trial evaluating the efficacy and safety of triple therapy with dulaglutide, SGLT2 inhibitors, and finerenone in Chinese ad…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-04-22Clinical Trial Update: A Clinical Trial of AP026 (TQA2226) for Injection in Adult Subjects. [Phase 1]
Phase 1 trial of AP026 (TQA2226) for injection in adults with Type 2 diabetes mellitus has been terminated.
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: To Test the Effectiveness and Implementation Approach of a 3-month PILI Pasifika Program Lifestyle Program With Components of Social Determinants of Health Activities in Real-world Settings (Clinical and Non-clinical Settings) Across 3 Years [NA]
A clinical trial protocol update outlining a 3-month PILI Pasifika lifestyle program with social determinants of health components to be eva…
-
CLINICAL_TRIALS trial_result · 2026-04-22Clinical Trial Update: A Virtual Cardiometabolic Health Program for African Immigrants: The Afro-DPP Program [NA]
Johns Hopkins University's Afro-DPP virtual cardiometabolic health program for African immigrants has completed the trial, with results post…
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: A Study to Evaluate the Effect of AZD6793 on the Pharmacokinetics and Pharmacodynamics of Metformin in Participants With Type 2 Diabetes Mellitus [Phase 1]
Phase 1 study assessing how AZD6793 affects the pharmacokinetics and pharmacodynamics of metformin in participants with type 2 diabetes mell…
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: Diabetes Multimorbidity Typology, Trajectory, and Feasibility of an Audio Diary Mobile Application to Support Self-management [NA]
A feasibility/trial update from Emory University describing a study of diabetes multimorbidity typology and trajectory and the feasibility o…
-
CLINICAL_TRIALS trial_result · 2026-04-22Clinical Trial Update: Adiponectin in Patients With Metabolic Disorders [NA]
A clinical trial evaluating adiponectin in patients with metabolic disorders including MAFLD and type 2 diabetes has completed.
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: Enhancing Diabetes Care by Treating Insomnia [NA]
Tulane University is conducting a study to see if treating insomnia can improve diabetes care in adults with Type 2 diabetes. The study has …
-
CLINICAL_TRIALS trial_result · 2026-04-22Clinical Trial Update: Influence of Preprandial Metformin Administration on Carbohydrate Absorption [NA]
A completed clinical trial evaluating whether preprandial administration of metformin affects carbohydrate absorption in individuals with im…
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: Food As MedicinE for Diabetes [NA]
A clinical trial titled 'Food As Medicine for Diabetes' conducted by the University of North Carolina, Chapel Hill has completed, studying a…
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: Cognitive-Behavioral Therapy and Exercise Training in Adolescents At-Risk for Type 2 Diabetes [NA]
This clinical trial is evaluating cognitive-behavioral therapy and exercise training for adolescents at risk of type 2 diabetes, with focus …
-
CLINICAL_TRIALS trial_result · 2026-04-22Clinical Trial Update: A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Tirzepatide in People With Type 2 Diabetes Treated With Metformin With or Without an SGLT2 Inhibitor [Phase 3]
A Phase 3 trial comparing CagriSema to tirzepatide in adults with Type 2 diabetes on metformin (with or without an SGLT2 inhibitor) has comp…
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: Pharmacist-led Continuous Glucose Monitoring
A University of South Florida–led study is recruiting to evaluate pharmacist-led continuous glucose monitoring in adults with Type 2 diabete…
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: STRIDE: Supporting Early Diabetes Self-Management for Parents [NA]
Kaiser Permanente sponsors the STRIDE trial to support early diabetes self-management for parents with Type 2 diabetes; the study is not yet…
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: Weight Loss in People Living With Overweight or Obesity and Type 2 Diabetes Following Treatment With Cagrilintide [Phase 3]
A Phase 3 clinical trial evaluating cagrilintide for weight loss in people with overweight/obesity and type 2 diabetes is currently active b…
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: Effect of an Early Time Restricted Eating Mediterranean Diet Compared to Naltrexone/Bupropion on Liver Fibrosis in People With Cardiometabolic Risk Factors in a Hospital Outpatient Clinic (MEDFAST-study) [Phase 4]
Phase 4 clinical trial comparing an early time-restricted eating Mediterranean diet to naltrexone/bupropion for liver fibrosis in adults wit…
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: ROME GS System Study [NA]
Senseonics, Inc. has a clinical trial that is currently recruiting for diabetes management, including type 1 and type 2 diabetes. No results…
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: Using Virtual Reality to Improve Medical Training [NA]
Ohio University is recruiting for a study using virtual reality to enhance medical training, focusing on Type 2 diabetes mellitus and relate…
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease [Phase 3]
A Phase 3 clinical trial is testing Vicadrostat together with empagliflozin in people with type 2 diabetes, hypertension, and cardiovascular…
-
CLINICAL_TRIALS trial_result · 2026-04-21Clinical Trial Update: Empagliflozin Versus Non-SGLT2 Oral Drugs for Blood Pressure in Type 2 Diabetes [Phase 4]
A Phase 4 trial comparing empagliflozin to non-SGLT2 oral medications for blood pressure in people with type 2 diabetes and hypertension has…
-
CLINICAL_TRIALS trial_result · 2026-04-21Clinical Trial Update: The Effect of Adherence to Oral Semaglutide on Glycaemic Control in People With Type 2 Diabetes Treated With Metformin
Terminated clinical trial evaluating the impact of adherence to oral semaglutide on glycemic control in people with type 2 diabetes treated …